Abstract:Comparing the survival times among two groups is a common problem in time-to-event analysis, for example if one would like to understand whether one medical treatment is superior to another. In the standard survival analysis setting, there has been a lot of discussion on how to quantify such difference and what can be an intuitive, easily interpretable, summary measure. In the presence of subjects that are immune to the event of interest (`cured'), we illustrate that it is not appropriate to just compare the overall survival functions. Instead, it is more informative to compare the cure fractions and the survival of the uncured sub-populations separately from each other. Our research is mainly driven by the question: if the cure fraction is similar for two available treatments, how else can we determine which is preferable? To this end, we estimate the mean survival times in the uncured fractions of both treatment groups ($MST_u$) and develop permutation tests for inference. In the first out of two connected papers, we focus on nonparametric approaches. The methods are illustrated with medical data of leukemia patients. In Part II we adjust the mean survival time of the uncured for potential confounders, which is crucial in observational settings. For each group, we employ the widely used logistic-Cox mixture cure model and estimate the $MST_u$ conditionally on a given covariate value. An asymptotic and a permutation-based approach have been developed for making inference on the difference of conditional $MST_u$'s between two groups. Contrarily to available results in the literature, in the simulation study we do not observe a clear advantage of the permutation method over the asymptotic one to justify its increased computational cost. The methods are illustrated through a practical application to breast cancer data.

Explained variation and degrees of necessity and of sufficiency for competing risks survival data

Explained Variation for Survival Models

Explained variation in shared frailty models

Explained Variation under the Additive Hazards Model

Survival Analysis in the Presence of Competing Risks

Exponent dependence measures of survival functions and correlated frailty models

Estimates of Marginal Survival for Dependent Competing Risks Based on an Assumed Copula

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Nomogram for survival analysis in the presence of competing risks.

Composite Partial Likelihood Estimation for Length-Biased and Right-Censored Data with Competing Risks

Generic solution of the heterogeneity-induced competing risk problem in survival analysis

Approximative Tests for the Equality of Two Cumulative Incidence Functions of a Competing Risk

Survivor average causal effects for continuous time: a principal stratification approach to causal inference with semicompeting risks

Efficient Estimation of Semiparametric Transformation Models for the Cumulative Incidence of Competing Risks

Maximum likelihood estimation of semiparametric mixture component models for competing risks data

Non-parametric cure rate estimation under insufficient follow-up using extremes

Competing risks and multivariate outcomes in epidemiological and clinical trial research

The survival function NPMLE for combined right-censored and length-biased right-censored failure time data: properties and applications

Conditional score approaches to errors‐in‐variables competing risks data in discrete time

Extended excess hazard models for spatially dependent survival data

A two-sample comparison of mean survival times of uncured sub-populations